New Treatment for Peritoneal Cancer - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
New Treatment for Peritoneal Cancer
19 Nov 2021

Gleneagles Hospital Hong Kong’s Peritoneal Malignancy Treatment Centre has introduced new intraperitoneal chemotherapy procedures, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), to provide more effective treatment to patients with peritoneal cancer.

Dr Kenneth Tsang, Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “In addition to our advanced radiotherapy facilities, we have also launched a centre dedicated to serving patients with peritoneal metastasis. Our experienced multidisciplinary medical team provides patients with comprehensive diagnostic services and personalised treatments.” The Centre is the first of its kind in Hong Kong catering to patients with peritoneal metastasis. Medical studies have found HIPEC to effectively improve the survival rate of patients with ovarian cancer, gastric cancer or colorectal cancer. The innovative PIPAC treatment is also known to relieve symptoms of peritoneal metastasis and reduce the side effects of chemotherapy, which helps improve the patient’s quality of life.

Topics:

Brands:

Related Stories

A New Chapter for Mount Elizabeth Hospital

For more than four decades, Mount Elizabeth Hospital has cared for generations of patients with a commitment to quality, compassion and medical excellence. Today, it begins a new chapter with the completion of Project Renaissance, its first major transformation since 1979.
19 Nov 2021
Read More

IHH Catalyst Launches in India with First Startup Cohort

10 startups. Four days in Gurgaon. Endless possibilities for better care.

19 Nov 2021
Read More

IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push

IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.

19 Nov 2021
Read More

IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia

At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.

19 Nov 2021
Read More
Parkway Shanghai Hospital in China Inaugurates Pan Vascular Centre 2026

Parkway Shanghai Hospital Inaugurates Pan Vascular Centre

The new multidisciplinary hub integrates six specialties to deliver full-cycle care for vascular diseases, reinforcing healthcare innovation in China.

19 Nov 2021
Read More
GHK Participates in 4th Red Cross City Challenge 2026

Gleneagles Hospital Hong Kong Participates in Fourth Red Cross City Challenge

Driven by IHH’s aspiration to “Care. For Good.”, Gleneagles Hospital Hong Kong continues its commitment to empower communities by continuously supporting humanitarian causes.

19 Nov 2021
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo